Results 121 to 130 of about 1,757,150 (280)

Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone

open access: yesJournal of Public Health in Africa, 2017
A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of
Nadege Goumkwa Mafopa   +13 more
doaj   +1 more source

Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo

open access: gold, 2023
Trésor Zola Matuvanga   +14 more
openalex   +2 more sources

Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo

open access: yesNature Medicine, 2021
E. Kinganda-Lusamaki   +28 more
semanticscholar   +1 more source

Monoclonal Antibody Therapy for Ebola Virus Disease.

open access: yesNew England Journal of Medicine, 2019
Early reports in 1976 and 1995 documented cases in the Democratic Republic of Congo (DRC) of what we now know to be Ebola virus disease (EVD) caused by Zaire ebolavirus.
M. Levine
semanticscholar   +1 more source

Nicotiana benthamiana as a Source of Cowpea Mosaic Virus‐Derived Particles That Specifically Package Designer RNAs

open access: yesPlant Biotechnology Journal, EarlyView.
ABSTRACT The coupling of replication and encapsidation in the bipartite plant virus, cowpea mosaic virus (CPMV), has been used to specifically incorporate designer RNA molecules into viral particles via transient expression in Nicotiana benthamiana. This is achieved by placing the desired RNA sequence between the 5′ and 3′ UTRs of CPMV RNA‐2 so that ...
H. Peyret   +5 more
wiley   +1 more source

Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction

open access: yesViruses, 2018
Since the largest 2014–2016 Ebola virus disease outbreak in West Africa, understanding of Ebola virus infection has improved, notably the involvement of innate immune mediators.
Anne-Laure Favier   +8 more
doaj   +1 more source

An overview of Ebola virus disease

open access: yesNorthern Clinics of Istanbul, 2016
(Uploaded by Plazi for the Bat Literature Project) Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush meat.
Kadanali, Ayten, Karagoz, Gul
openaire   +2 more sources

Long-lasting severe immune dysfunction in Ebola virus disease survivors

open access: yesNature Communications, 2019
Long-term follow up studies from Ebola virus disease (EVD) survivors (EBOV_S) are lacking. Here, we evaluate immune and gene expression profiles in 35 Guinean EBOV_S from the last West African outbreak, a median of 23 months (IQR [18–25]) after discharge
A. Wiedemann   +23 more
semanticscholar   +1 more source

Protein‐Derived Signal Peptides Induced by Agrobacterium Infection Promote the Secretion of Recombinant Proteins in Nicotiana benthamiana

open access: yesPlant Biotechnology Journal, EarlyView.
ABSTRACT Plants are promising next‐generation hosts for recombinant protein production; however, major challenges remain with regard to enhancing the efficiency of downstream processing, particularly in the removal of cellular residues and purification of the expressed proteins.
Hiroyuki Kajiura   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy